Literature DB >> 29249186

Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia.

Nathan D Gay1, Eliana Kozin2, Craig Okada1, Alexey V Danilov1, Stephen Spurgeon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29249186     DOI： 10.1080/10428194.2017.1410890

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL.

Authors:  Rohitashva Agrawal; Reinhold Munker; Maxwell M Krem
Journal:  EJHaem       Date:  2020-08-12

2.  Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia.

Authors:  Sharad Khurana; Salman Ahmed; Victoria R Alegria; Sonikpreet Aulakh; Meghna Ailawadhi; Anshika Singh; Asher Chanan-Khan; Sikander Ailawadhi
Journal:  SAGE Open Med Case Rep       Date:  2019-01-16

Review 3.  Chronic lymphocytic leukemia treatment algorithm 2018.

Authors:  Sameer A Parikh
Journal:  Blood Cancer J       Date:  2018-10-03       Impact factor: 11.037
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.